Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:24 AM UTC
| NCT Number | NCT06925737 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,440 participants |
| Active Locations | 51 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT06925737 is currently recruiting participants. This phase3 study for prostate cancer is actively seeking new participants at 51 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06925737 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06925737 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.